Bozzatello P., Novelli R., Schisano R. et al. New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology? Pharmaceuticals. 2025;18(5):665. DOI: 10.3390/ph18050665.
IsHak W.W., Hirsch D., Renteria S. et al. Depressive disorders: systematic review of approved psychiatric medications (2009–April 2025) and pipeline phase 3 medications. BMC Psychiatry. 2025;25:939. DOI: 10.1186/s12888-025-07141-3.
U.S. Food and Drug Administration. FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia. April 30, 2026.